Call for patient input on ruxolitinib (Opzelura®) for atopic dermatitis - Arthritis News If you live with atopic dermatitis or care for someone with atopic dermatitis, please send us your input by April 2, 2026. Your input will be anonymous.

JointHealth™ express - Call for patient input on ruxolitinib (Opzelura®) for atopic dermatitis. Learn more: bit.ly/ACE_CDAPatie...

#AtopicDermatitis #PatientInput

@arthritispower.bsky.social @schroeder-uhn.bsky.social @arthritistrainees.bsky.social @arthritis-ubc.bsky.social

Call for patient input on inebilizumab (Uplizna®) for immunoglobulin G4-related disease - Arthritis News If you live with immunoglobulin G4-related disease or care for someone with immunoglobulin G4-related disease, please send us your input by March 19, 2026.

JointHealth™ express - Call for patient input on inebilizumab (Uplizna®) for immunoglobulin G4-related disease.

Learn more: bit.ly/ACE_CDAPatie...

#patientinput @schroeder-uhn.bsky.social @arthritispower.bsky.social @arthritistrainees.bsky.social @arthritisdietitian.bsky.social

Let BC PharmaCare hear Your Voice on sarilumab (Kevzara®) for the treatment of polymyalgia rheumatica in adults - Arthritis News You can give input if you are a B.C. resident and an adult living with polymyalgia rheumatica, a caregiver to an adult living with polymyalgia rheumatica, or if your group represents adults living wit...

JointHealth™ express - Let BC PharmaCare hear Your Voice on sarilumab (Kevzara®) for the treatment of polymyalgia rheumatica in adults. Learn more: bit.ly/JHEBCYourVoi...

#patientinput @arthritispower.bsky.social @arthritis-ubc.bsky.social @fraserhealth.ca @providencehealthcare.org

Call for patient input on anifrolumab (Saphnelo®) for systemic lupus erythematosus - Arthritis News If you are a patient or caregiver of someone living with systemic lupus erythematosus, we want to hear from you!

JointHealth™ express - Call for patient input on anifrolumab (Saphnelo®) for systemic #lupus erythematosus.

Learn more: bit.ly/ACECDAPatien...

#SLE #patientinput #ACEAdvocacy @arthritispower.bsky.social @lupuschat.bsky.social @fibroandlupus.bsky.social @schroeder-uhn.bsky.social

Call for patient input on roflumilast (Zoryve®) for plaque psoriasis - Arthritis News If you are a patient or caregiver of someone living with plaque psoriasis, we want to hear from you!

JointHealth™ express - Call for patient input on roflumilast (Zoryve®) for plaque psoriasis. Send your input to feedback@jointhealth.org.

Learn more: bit.ly/JHECDAPatien...

#patientinput #plaquepsoriasis

Let BC PharmaCare hear Your Voice on upadacitinib (Rinvoq®) for the treatment of giant cell arteritis - Arthritis News BC PharmaCare is looking for your input on upadacitinib (Rinvoq®) for the treatment of giant cell arteritis.

JointHealth™ express - Let BC PharmaCare hear Your Voice on upadacitinib (Rinvoq®) for the treatment of giant cell arteritis.

Learn more: bit.ly/JHEBCYourVoi...

#GCA #patientinput

@arthritistrainees.bsky.social
@arthritisdietitian.bsky.social
@inesss.qc.ca
@arthritispower.bsky.social

Let BC PharmaCare hear Your Voice on roflumilast cream (Zoryve®) for the treatment of atopic dermatitis in patients 6 years of age and older - Arthritis News BC PharmaCare is looking for your input on roflumilast cream (Zoryve®) for the treatment of atopic dermatitis in patients 6 years of age and older.

JointHealth™ express - Let BC PharmaCare hear Your Voice on roflumilast cream (Zoryve®) for the treatment of atopic dermatitis in patients 6 years of age and older.

Learn more: bit.ly/JHEBCYourVoi...

#patientinput

@arthritispower.bsky.social
@schroeder-uhn.bsky.social
@lupuschat.bsky.social

Today is the last day to complete our survey about living with polymyalgia rheumatica (PMR)! This is your chance to share your experience and help shape access to treatment.

Learn more + add your voice: buff.ly/2LUuZry

#PMR #Kevzara #PatientInput #PatientVoice

JointHealth™ express - Call for patient input on upadacitinib (Rinvoq) for giant cell arteritis. Send your input to feedback@jointhealth.org. Learn more: bit.ly/CDAupadaciti...

#GCA #patientinput @schroeder-uhn.bsky.social @arthritispower.bsky.social @ualberta.bsky.social @arthritis-ubc.bsky.social